Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001933414-25-000017
Filing Date
2025-02-24
Accepted
2025-02-24 18:59:23
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740441556.html 4  
1 FORM 4 wk-form4_1740441556.xml 4 10131
  Complete submission text file 0001933414-25-000017.txt   12322
Mailing Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035
Business Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035 81 90-3536-3820
Catalys Pacific Fund, LP (Reporting) CIK: 0001746274 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 25658716

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MINERALYS THERAPEUTICS, INC. 150 N. RADNOR CHESTER RD, STE. F200 RADNOR PA 19087
Business Address
Slingsby Brian Taylor (Reporting) CIK: 0001963901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 25658717